Newest video updates regarding Coronavirus. Check out this “Can recurring breast cancer be spotted with AI tech? – BBC News” video below:
The risk of recurring breast cancer in patients is being assessed using AI in a trial in one of the world’s leading cancer centres.
At Gustave Roussey hospital in Paris, a non-intervention clinical trial is taking place using AI to digitise more than 1,500 tissue samples from women with breast cancer.
French and US tech company Owkin has partnered with the hospital to run the trial aiming…..(read more)
Leave a Reply